Ventura County Medical Center | |
300 Hillmont Avenue, Ventura, California 93003 | |
(805) 652-6075 | |
Name | Ventura County Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 300 Hillmont Avenue, Ventura, California |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 050159 |
NPI Number | 1003146366 |
Organization Name | VENTURA COUNTY MEDICAL CENTER |
Address | 200 Hillmont Ave, Ventura, CA 93003 |
Hospital Type | Psychiatric Hospital |
Phone Number | 805-652-6729 |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
NPI Number | 1053430108 |
Organization Name | COUNTY OF VENTURA |
Doing Business As | VCMC INPATIENT SERVICES |
Address | 200 Hillmont Ave, Ventura, CA 93003 |
Hospital Type | Psychiatric Hospital |
Phone Number | 805-652-6729 |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
NPI Number | 1144471780 |
Organization Name | HILLMONT PSYCHIATRIC CENTER |
Address | 200 Hillmont Ave, Ventura, CA 93003 |
Hospital Type | Psychiatric Hospital |
Phone Number | 805-652-6729 |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
NPI Number | 1417999137 |
Organization Name | VENTURA COUNTY MEDICAL CENTER |
Address | 300 Hillmont Ave, Ventura, CA 93003 |
Hospital Type | General Acute Care Hospital |
Phone Number | 805-652-6000 |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
NPI Number | 1437315587 |
Organization Name | VENTURA COUNTY MEDICAL CENTER PSYCHIATRIC UNIT |
Address | 3291 Loma Vista Rd, Ventura, CA 93003 |
Hospital Type | Psychiatric Hospital |
Phone Number | 805-652-6729 |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | No |
News Archive
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson's disease and multiple sclerosis.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
› Verified 5 days ago
Ventura County Medical Center Acute Care Hospital Location: 300 Hillmont Avenue, Ventura, California 93003 Phone: (805) 652-6075 | |
Community Memorial Hospital San Buenaventura Acute Care Hospital Location: 147 N Brent St, Ventura, California 93003 Phone: (805) 652-5011 | |
Aurora Vista Del Mar Hospital Psychiatric Hospital Location: 801 Seneca St, Ventura, California 93001 Phone: (805) 653-6434 |